title: Pineal region tumours treated with interstitial brachytherapy with low activity sources (192-iridium).
abstract: Three patients with tumours of the pineal region underwent interstitial Ir-192 brachytherapy. Histological diagnoses were obtained in all patients, by stereotactic biopsy and included one germinoma, one mixed pineoblastoma/pineocytoma, and one astrocytoma grade III. Our approach to pineal region neoplasms is first to decide whether stereotactic biopsy or surgery should be performed. When a pineal lesion is thought to be benign on the basis of imaging, such as benign teratoma, surgery is performed to resect the entire lesion. When a definitive diagnosis is not possible, stereotactic biopsy is performed to obtain a histological diagnosis for treatment planning, using a Brown-Roberts-Wells (BRW) stereotactic apparatus with computed tomography (CT) or magnetic resonance imaging (MRI). When a lesion is malignant and localized, stereotactic implantation of catheters for interstitial brachytherapy is performed simultaneously. Radioactive Ir-192 seeds are inserted into the catheters and maintained for 5-10 days to give 36 Gy of irradiation at the tumour periphery. Sequential CT scans and MRI after treatment revealed tumour disappearance in two patients with germinoma and high grade astrocytoma and tumour reduction in the patient with mixed pineoblastoma/pineocytoma. No significant morbidity or mortality occurred in any of these patients after stereotactic biopsy and brachytherapy. The technique and the advantages of this therapeutic approach to selected pineal region tumours are described and discussed.
authors: Department of Neurological Surgery, Okayama University Medical School, Japan.
authors: K
authors: K
authors: Matsumoto
authors: H
authors: H
authors: Higashi
authors: S
authors: S
authors: Tomita
authors: T
authors: T
authors: Ohmoto
mesh_terms: D000328:Adult; D001706:Biopsy / Q000295:instrumentation; D001918:Brachytherapy / Q000295:instrumentation*; D001932:Brain Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D016371:Cranial Irradiation / Q000295:instrumentation*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005909:Glioblastoma / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000295:instrumentation; D008297:Male; D010870:Pineal Gland / Q000473:pathology / Q000528:radiation effects*; D010871:Pinealoma / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000295:instrumentation; D013238:Stereotaxic Techniques / Q000295:instrumentation
chemical_list: D007496:Iridium Radioisotopes